Venus Remedies Limited (VENUSREM.NS) NSE

Currency In INR

AD

Valuation

Market Cap10.96B
Enterprise Value10.78B
P/E Ratio16.96
PEG Ratio0.15
Price/Sales Ratio2.43
Price/Book Ratio2.97
Enterprise/Revenue2.43
Enterprise/EBITDA11.24

Fiscal Year

Fiscal YearMarch 31, 2026
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin0.14
Operating Margin0.17
AD

Management Effectiveness

Return On Assets0
Return On Equity0.18

Income Statement

Revenue7.7B
Revenue/Share606.92
Gross Profit2.68B
EBITDA1.6B
Net Income1.03B
Diluted EPS76.89

Balance Sheet

Total Cash1.03B
Total Cash/Share0
Total Debt0
Total Debt/Equity0
Current Ratio0
Book Value Per Share496.56

Price History

52-Week Change227.71
52-Week High2,044.3
52-Week Low294.15
Moving Average 50 Days1,661.08
Moving Average 200 Days1,272.87

Statistics

Average Volume35,640
Shares Outstanding13.37M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate10
Trailing Annual Dividend Yield0.68
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A
AD